Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC4746 Sj521054
Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interaction (IC50 0.40 μM)
More description
DCC4745 Sj3366
Unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1), also inhibiting HIV-2
More description
DCC4744 Sj1008066
Novel inhibitor of MAGE-A11 with robust activity in TR-FRET for disrupting MAGE-A11:PCF11 interactionm being cell permeable and having improved activity in the TR-FRET assay (IC50 0.13 µM)
More description
DCC4743 Si-w052
Novel inhibitor of lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α and interleukin (IL)-6 on microglia, exhibiting anti-inflammatory activity through ER-stress-mediated autophagy, significantly inducing the conversion ratio of LC3 II/I and
More description
DCC4742 Sitafloxacin Monohydrate
Fluoroquinolone antibiotic, acting as antibacterial, antineoplastic, anti-Infective agents, Inhibiting DNA-gyrase and topoisomerase
More description
DCC4741 Sitafloxacin
Potent broad spectrm fluoroquinolone antibiotic
More description
DCC4740 Sir-tz
Novel in situ tetrazine ligation reactive silicon-rhodamine dye
More description
DCC4739 Sirt3 Inhibitor P6
Novel selective SIRT3 inhibitor, exhibiting SIRT3 inhibitory selectivity with IC50 value of 7.2 µM over SIRT1 (32.6 µM) and SIRT2 (33.5 µM), showing potent inhibitory activity against a group of MLLr leukemic cell lines
More description
DCC4738 Sirt2-in-6f
Potent and selective inhibitor of SIRT2
More description
DCC4737 Sirt1-in-4bb
Novel SIRT1 inhibitor, inducing apoptosis in HCT116 human colon carcinoma cells partially by activating p53
More description
DCC4736 Sirt1-i5
Novel SIRT1 Inhibitor, showing potent effect on prostate cancer cell line
More description
DCC4735 Sirt1-enhancer-a03
First-in-class apolipoprotein E4 (ApoE4)-targeted sirtuin1 (SirT1) enhancer, normalizing sirtuin 1 levels and improving cognition in an Alzheimer's disease mouse model
More description
DCC4734 Sirt1-a2
Novel SIRT1 Activator
More description
DCC4733 Sipi-7623
Novel farnesoid X receptor antagonist
More description
DCC4732 Sipi-6360
Novel D2/5-HT2A Receptor Dual Antagonist
More description
DCC4731 Sinapine Sulfate
Antioxidant and antimicrobial agent, counteracting mitochondrial oxidative stress in cardiomyocytes
More description
DCC4730 Simfibrate
Peroxisome proliferator
More description
DCC4729 Sila-ibuprofen
Novel COX-I and COX-II inhibitor with four times higher solubility in physiological media and a lower melting enthalpy than ibuprofen
More description
DCC4728 Silagaba161
Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects
More description
DCC4727 Silagaba132
Silicon-Containing GABA Derivative, Treating Neuropathic Pain without Central-Nervous-System-Related Side Effects
More description
DCC4726 Sid-7977382
Novel Complement Factor C1 Inhibitor
More description
DCC4725 Sid-24784551
Novel direct HIV-1 Nef antagonist with antiretroviral activity
More description
DCC4724 Sibopirdine
Novel cognitive enhancer; Nootropic agent
More description
DCC4723 Shr0687
Highly Potent and Peripheral Nervous System-Restricted KOR Agonist
More description
DCC4722 Shp2 Inhibitor C21
Inhibitor of shp2 protein tyrosine phosphatase (PTP)
More description
DCC4721 Showdomycin
Antineoplastic antibiotic
More description
DCC4720 Ship-2a
Cystathione gamma lyase (CSE) inhibitor, inhibiting H2S production and L-cysteine-induced relaxation of rat aortic rings ex vivo
More description
DCC4719 Shield-2
Novel potent stabilizing ligand for FKBP-derived destabilizing domains
More description
DCC4718 Sh-i-14
Novel Inhibitor of Phospho-STAT3 Through Induction of Protein Tyrosine Phosphatase PTPN6
More description
DCC4717 Sheta2
Selective inhibitor of cancer cell growth, exerting chemoprevention activity without evidence of toxicity
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X